OT: Nerds chatting [Bioanalytics]

posted by nobody – 2019-03-28 11:14 (662 d 00:34 ago) – Posting: # 20101
Views: 3,635

...and even worse (re Danish footer)

The FDA ordered AbbVie to stop recruiting multiple myeloma patients for a Phase III trial of its anti-cancer drug Venclexta/Venclyxto.

Forty-one out of 194 patients taking AbbVie’s Venclexta (venetoclax) in the company’s trial have died, the FDA found, nearly twice the percent of the patients in the trial’s placebo arm.

Kindest regards, nobody

Complete thread:

 Admin contact
21,303 posts in 4,441 threads, 1,487 registered users;
online 12 (0 registered, 12 guests [including 5 identified bots]).
Forum time: Monday 11:49 CET (Europe/Vienna)

I believe there is no philosophical high-road in science,
with epistemological signposts. No, we are in a jungle
and find our way by trial and error,
building our road behind us as we proceed.    Max Born

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz